Company Wants to Sell Testosterone Self-Injector

Jinzang said:

I haven't seen this mentioned. Seems like a waste of money to me, but might expand the market for TRT for the injection averse.

Antares Pharma, Inc. announced that it had submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for QuickShot® Testosterone (QST), a drug-device combination product for the delivery of testosterone enanthate using a subcutaneous auto injector. QST is intended to treat adult men with low testosterone associated with a condition known as hypogonadism.

So far only the financial press have picked up the story,

Click to expand...

johndoesmith said:

Seems as if this has already been invented...

View attachment 2926

Click to expand...

Nelson Vergel said:

JohnDoeSmith

FDA approvals are not only for new inventions but for new methods of delivery. This application gives the rights to a company to charge a lot more money for an injector and a generic product like testosterone cypionate for insurance companies to cover. That is the reason why there are several FDA approved testosterone gels in the market that do the same thing- No new inventions but just a license to get insurance payments at 50 times what a compounding pharmacy charges. Crazy rules, I know.

Click to expand...